Cas no 2680-59-3 (1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol)
1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol Chemical and Physical Properties
Names and Identifiers
-
- 1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol
- 1-PALMITIN-2-OLEIN-3-LINOLEIN
- 1-Palmitoyl-2-oleoyl
- [1-hexadecanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropan-2-yl] (Z)-octadec-9-enoate
- DB-364458
- Linolein, 2-oleo-3-palmito-1-
- 9,12-Octadecadienoic acid (9Z,12Z)-,3-[(1-oxohexadecyl)oxy]-2-[[(9Z)-1-oxo-9-octadecenyl]oxy]propyl ester
- 9,12-Octadecadienoic acid (9Z,12Z)-, 3-((1-oxohexadecyl)oxy)-2-(((9Z)-1-oxo-9-octadecen-1-yl)oxy)propyl ester
- 9,12-Octadecadienoic acid (Z,Z)-, 3-((1-oxohexadecyl)oxy)-2-((1-oxo-9-octadecenyl)oxy)propyl ester, (Z)-
- G90973
- S6K38J8R5G
- PD020878
- 2680-59-3
- TG 16:0_18:1_18:2
- CHEBI:190960
- J-016552
- Olein, 1-linoleo-3-palmito-2-
- (9Z,12Z)-2-(Oleoyloxy)-3-(palmitoyloxy)propyl octadeca-9,12-dienoate
- UNII-S6K38J8R5G
- 9,12-Octadecadienoic acid (9Z,12Z)-, 3-((1-oxohexadecyl)oxy)-2-(((9Z)-1-oxo-9-octadecenyl)oxy)propyl ester
- Palmitin, 3-linoleo-2-oleo-1-
- (9Z,12Z)-9,12-Octadecadienoic Acid 3-[(1-Oxohexadecyl)oxy]-2-[[(9Z)-1-oxo- 9-octadecen-1-yl]oxy]propyl Ester
- SCHEMBL2733312
- DTXSID801345857
- 1-Palmitoyl-2-oleoyl-3-linolein
- 1587-93-5
- 1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol, >=98%
- HMS3649G11
- SR-01000947057
- SR-01000947057-1
- 2-Oleo-3-palmito-1-linolein
- 2-[(9Z)-9-OCTADECENOYLOXY]-3-(PALMITOYLOXY)PROPYL (9Z,12Z)-9,12-OCTADECADIENOATE
-
- Inchi: 1S/C55H100O6/c1-4-7-10-13-16-19-22-25-27-30-33-36-39-42-45-48-54(57)60-51-52(50-59-53(56)47-44-41-38-35-32-29-24-21-18-15-12-9-6-3)61-55(58)49-46-43-40-37-34-31-28-26-23-20-17-14-11-8-5-2/h16,19,25-28,52H,4-15,17-18,20-24,29-51H2,1-3H3/b19-16+,27-25+,28-26+
- InChI Key: KGLAHZTWGPHKFF-QEKWMWMASA-N
- SMILES: CCCCCCCCCCCCCCCC(OCC(OC(CCCCCCC/C=C/CCCCCCCC)=O)COC(CCCCCCC/C=C/C/C=C/CCCCC)=O)=O
Computed Properties
- Exact Mass: 856.75200
- Monoisotopic Mass: 856.75199091g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 6
- Heavy Atom Count: 61
- Rotatable Bond Count: 51
- Complexity: 1030
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 1
- Defined Bond Stereocenter Count: 3
- Undefined Bond Stereocenter Count: 0
- XLogP3: 21.6
- Topological Polar Surface Area: 78.9?2
Experimental Properties
- Density: 0.9±0.1 g/cm3
- Melting Point: N/A
- Boiling Point: 801.4±55.0 °C at 760 mmHg
- Flash Point: 298.5±31.5 °C
- Solubility: Chloroform (Slightly), Ethyl Acetate (Slightly)
- PSA: 78.90000
- LogP: 17.31690
- Vapor Pressure: 0.0±2.8 mmHg at 25°C
1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol Security Information
- Signal Word:warning
- Hazard Statement: H303+H313+H333
- Warning Statement: P264+P280+P305+P351+P338+P337+P313
- WGK Germany:3
- Safety Instruction: H303+H313+H333
- Storage Condition:Refrigerator
1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | P8577-100MG |
1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol |
2680-59-3 | ≥98% | 100MG |
9815.7 | 2021-05-14 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajci68302-10mg |
1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol |
2680-59-3 | 98% | 10mg |
¥1100.00 | 2022-04-26 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajci68302-5mg |
1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol |
2680-59-3 | 98% | 5mg |
¥620.00 | 2022-04-26 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajci68302-50mg |
1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol |
2680-59-3 | 98% | 50mg |
¥4463.00 | 2022-04-26 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajci68302-100mg |
1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol |
2680-59-3 | 98% | 100mg |
¥7520.00 | 2022-04-26 | |
| TRC | P162000-5mg |
1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol |
2680-59-3 | 5mg |
$ 64.00 | 2023-09-06 | ||
| TRC | P162000-10mg |
1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol |
2680-59-3 | 10mg |
$ 108.00 | 2023-09-06 | ||
| TRC | P162000-25mg |
1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol |
2680-59-3 | 25mg |
$247.00 | 2023-05-17 | ||
| TRC | P162000-50mg |
1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol |
2680-59-3 | 50mg |
$ 430.00 | 2023-09-06 | ||
| TRC | P162000-100mg |
1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol |
2680-59-3 | 100mg |
$781.00 | 2023-05-17 |
1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol Suppliers
1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol Related Literature
-
Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
-
Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
-
Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
-
Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
-
5. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
Additional information on 1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol
Recent Advances in the Study of 1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol (CAS: 2680-59-3) and Its Applications in Chemical Biology and Medicine
1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol (CAS: 2680-59-3) is a structured triglyceride that has garnered significant attention in the fields of chemical biology and medicine due to its unique biochemical properties and potential therapeutic applications. This research briefing synthesizes the latest findings on this compound, focusing on its synthesis, characterization, and biological activities, as well as its role in drug delivery systems and metabolic studies.
Recent studies have highlighted the importance of 1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol in lipid metabolism and its potential as a biomarker for metabolic disorders. Advanced analytical techniques, such as mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy, have been employed to elucidate its structural and functional properties. These studies have revealed that the compound exhibits high stability and bioavailability, making it a promising candidate for pharmaceutical formulations.
In the context of drug delivery, 1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol has been investigated as a carrier for hydrophobic drugs, enhancing their solubility and therapeutic efficacy. Research has demonstrated that this triglyceride can form stable micelles and liposomes, which are effective in targeted drug delivery. Furthermore, its biocompatibility and low toxicity profile make it an attractive option for developing novel nanomedicines.
Another area of interest is the compound's role in modulating inflammatory responses and oxidative stress. Preclinical studies have shown that 1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol can influence the production of pro-inflammatory cytokines and reactive oxygen species, suggesting its potential application in treating inflammatory diseases and conditions associated with oxidative damage. These findings are supported by in vitro and in vivo experiments, which have provided mechanistic insights into its anti-inflammatory and antioxidant properties.
Despite these advancements, challenges remain in the large-scale production and clinical translation of 1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol-based therapies. Current research is focused on optimizing synthetic routes and improving the scalability of production processes. Additionally, further studies are needed to fully understand the compound's pharmacokinetics and pharmacodynamics in humans.
In conclusion, 1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol (CAS: 2680-59-3) represents a versatile and promising molecule in chemical biology and medicine. Its applications in drug delivery, metabolic regulation, and inflammation modulation underscore its potential to address unmet medical needs. Future research should prioritize translational studies to bridge the gap between laboratory findings and clinical applications, paving the way for innovative therapeutic solutions.
2680-59-3 (1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol) Related Products
- 2442-62-8(1,2-Dilinoleoylglycerol)
- 23314-57-0(5,8,11,14-Eicosatetraenoicacid, 1,1',1''-(1,2,3-propanetriyl) ester,(5Z,5'Z,5''Z,8Z,8'Z,8''Z,11Z,11'Z,11''Z,14Z,14'Z,14''Z)-)
- 2190-15-0(1,2-Dilinoleoyl-3-palmitoyl-rac-glycerol)
- 106292-55-1(rac 1-Oleoyl-2-linoleoylglycerol)
- 14465-68-0(Trilinolenin)
- 2190-20-7(1,2-Dioleoyl-3-linoleoyl-rac-glycerol (>90%))
- 2190-21-8(1,2-Dilinoleoyl-3-oleoyl-rac-glycerol)
- 2190-16-1(9,12-Octadecadienoicacid (9Z,12Z)-, 1,1'-[2-[(1-oxohexadecyl)oxy]-1,3-propanediyl] ester)
- 129691-30-1(8,11,14-Eicosatrienoicacid, 1,2,3-propanetriyl ester (9CI))
- 32373-20-9(9,12,15-Octadecatrienoic acid,2-[(1-oxohexadecyl)oxy]-1-[[(1-oxohexadecyl)oxy]methyl]ethyl ester,(9Z,12Z,15Z)-)